Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Mario Campone
Based on 114 articles published since 2007
||||
Expertise Level
The expertise of Mario Campone ranks in the
  • Top 0.012%
  • ... of 251,815 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 114 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Campone, Mario   ·   Campone, M
Work Locations
Details
Most likely:    ICO Rene Gauducheau      
2017
  • a Medical oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St Herblain , France. · b Medical oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 28395540
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Centre Eugène Marquis, Rue de la Bataille Flandres-Dunkerque - CS 44229, 35042 Rennes Cedex, France. Electronic address: · Centre Georges-François Leclerc, 1 rue Professeur Marion BP 77990, 21079 Dijon, France. Electronic address: · Institut régional du cancer de Montpellier, Parc Euromédecine, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France. Electronic address: · Centre François Baclesse, 3 av du Général Harris, 14000 Caen, France. Electronic address: · Centre Catherine de Sienne, 2 rue Eric Tabarly, 44202 Nantes, France. Electronic address: · Centre Hospitalier, Avenue de l'Hopital, 12000 Rodez, France. Electronic address: · Centre Paul Papin, 15 rue André Boquel, 49000 Angers, France. Electronic address: · Centre Alexis Vautrin, 6 avenue de Bourgogne, 54419 Vandoeuvre-Lès-Nancy, France. Electronic address: · Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. Electronic address: · Institut Curie, Site de Saint-Cloud, 35 rue Dailly, 92210 Saint-Cloud, France. Electronic address: · Institut Sainte-Catherine, 250 Chemin de Baigne Pieds, 84918 Avignon, France. Electronic address: · Centre hospitalier Émile Müller, 20 rue du Docteur Laennec, 68051 Mulhouse, France. Electronic address: · Institut Bergonié, 229 Cours de l'Argonne, 33000 Bordeaux, France. Electronic address: · Institut de cancérologie de l'ouest, Centre René Gauducheau, Boulevard Professeur Jacques Monod, 44805 Saint-Herblain, France. Electronic address: · Centre Jean Perrin, 58 rue Montalembert, 63000 Clermont-Ferrand, France. Electronic address: · Centre Léon Bérard, 28 prom. Léa et Napoléon Bullukian, 69008 Lyon, France. Electronic address: · Centre hospitalier Bretagne-Sud, 5 avenue de Choiseul, 56322 Lorient, France. Electronic address: · Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-Oncopole, 1 avenue Irèle joliot-Curie, 31059 Toulouse Cedex 9, France. Electronic address: · Pubmed 28501763
  • Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy. · Institut de Cancerologie de l'Ouest, René Gauducheau, Saint-Herblain, France. · Hospital Gasthuisberg, Leuven, Belgium. · Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA. · Pontificia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Duke University Medical Center, Durham, NC, USA. · Moffitt Cancer Center, Tampa, FL, USA. · University of Szeged, Szeged, Hungary. · Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, Bordeaux, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Institut Gustave Roussy, Villejuif, France. · Pubmed 28183331
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Curtin University and Breast Cancer Research Centre, Perth, Australia. · Department of Oncological Research, Sint-Augustinus Hospital, Antwerp, Belgium. · Baylor-Charles A. Sammons Cancer Center, Dallas, USA Texas Oncology, US Oncology, Dallas, USA. · Centro de Oncologia Clínica, Hospital Pérola Byington and FMUSP, Paulo São, Brazil. · City Clinical Oncological Dispensary, Saint Petersburg, Russian Federation. · Hematology and Medical Oncology, Ironwood Cancer and Research Centers, Chandler, USA. · Department of Breast Tumors, Petrov Research Institute of Oncology, Saint Petersburg, Russian Federation. · Medical Oncology Service, Hospital Universitario de Canarias, Tenerife, Spain. · Institut de Cancérologie de l'Ouest, Nantes René Gauducheau Centrede Recherche en Cancérologie, France. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain. · University of Kansas Medical Center, University of Kansas, Kansas City. · Highlands Oncology Group, Fayetteville, USA. · Centro Oncológico de Galicia, La Coruña, Spain. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover. · Novartis Institutes for BioMedical Research, Cambridge, USA. · Novartis Oncology, Paris, France. · Breast Cancer Group, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 27803006
  • a Department of Medical Oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St. Herblain , France. · b Department of Medical Oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Nantes and Angers , Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 29169282
  • Loire-Atlantique/Vendée Cancer Registry, Plateau des écoles, 50 route de St Sébastien, 44093, Nantes Cedex 1, France. · Loire-Atlantique/Vendée Cancer Registry, Plateau des écoles, 50 route de St Sébastien, 44093, Nantes Cedex 1, France. · Institut de Cancérologie de l'Ouest, Site René Gauducheau, Boulevard Jacques Monod, 44805, St Herblain Cedex, France. · CAP Santé Plus 44, 50 route de St Sébastien, CS 96531, 44265, Nantes, France. · Pubmed 27995351
2016
  • a Centre René Gauducheau, Institut de Cancérologie de l'Ouest , Boulevard Jacques Monod, Saint-Herblain , France. · b Centre Eugène Marquis , Boulevard de la Bataille Flandres-Dunkerque, Rennes , France. · c Centre Paul Papin, Institut de Cancérologie de l'Ouest , 15 rue André Bocquel, Angers , France. · d UMR INSERM U892 , France. · Pubmed 27484180
  • Previous address: Churchill Hospital, Oxford University Hospitals NHS Trust and University of Oxford, Oxford, United Kingdom. · School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom. · Department of Oncology, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, United Kingdom. · Department of Oncology, Highlands Oncology Group, Fayetteville, Arkansas, USA. · Department of Oncology, Hospital Clinico Universitario, Santiago de Compostela, Spain. · Department of Medical Oncology, Nuovo Ospedale di Prato, Prato, Italy. · Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Department of Medical Oncology, University of Torino, FPO-IRCCS, Candiolo, Italy. · Department of Medical Oncology, University Hospital, IBIMA, Malaga, Spain. · Department of Medical Oncology, Institut de Cancérologie de l'ouest René Gauducheau, Nantes, France. · Early Clinical Biostatistics, Oncology, Novartis Pharma AG, Basel, Switzerland. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · Oncology Global Development, Novartis Pharma AG, Basel, Switzerland. · Department of Hematology-Oncology, National University Cancer Institute Singapore, Singapore. · Pubmed 27129177
  • Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain · Medical Oncology, Georges Francois Leclerc Centre, Dijon, France. · Department of Oncology, Ninewells Hospital, Dundee, UK. · Medical Oncology, Hospital del Mar, Barcelona Cancer Research Program, IMIM, Barcelona CEXS, Ponpeu Fabra University, Barcelona, Spain. · Hematology -Medical Oncology Department, Levine Cancer Institute, Charlotte, USA. · Medical Oncology, Institute of Cancer Research (ICO) in Western France, Nantes, France. · Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, USA. · Pharma Development Oncology. · Department of Biostatistics. · Oncology Biomarker Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, USA. · Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain. · Pubmed 27052654
  • Institut Paoli-Calmettes, Medical Oncology Department, Marseille, France. · CRO2, Neuro-Oncology Department, UMRS_911, Marseille, France. · APHM, Marseille, France. · Aix-Marseille University, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, Inserm, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, CNRS, Marseille, France. · Institut Curie & Université Paris Descartes, Medical Oncology Department, Paris, France. · Centre Paul Strauss, Medical Oncology Department, Strasbourg, France. · Centre François Baclesse, Medical Oncology Department, Caen, France. · Centre Antoine Lacassagne, Medical Oncology Department, Nice, France. · Centre René Gauducheau, Medical Oncology Department, Saint-Herblin, France. · APHP-Tenon, APREC, Paris, France. · IUC-UPMC, Sorbonne University, Paris, France. · Hopital Rene Huguenin-Institut Curie, Medical Oncology Department, Saint-Cloud, France. · Institut Claudius Regaud, Medical Oncology Department, Toulouse, France. · Institut Leon Berard, Medical Oncology Department, Lyon, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium. · Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Department of Oncology, KU Leuven, Leuven, Belgium. · The University of Texas MD Anderson Cancer Center, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX, USA. · Pubmed 26921265
  • Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Present address: Institut Curie, Centre de Recherche, UMR 144, 26 Rue d'Ulm, 75248, Paris, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Institut de Cancérologie de Nantes, Centre de Lutte Contre le Cancer René Gauducheau, Boulevard Jacques Monod, 44 805, Saint-Herblain-Nantes Cedex, France. · Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Pubmed 27039296
  • EA 4275-SPHERE methodS for Patients-centered outcomes and HEalth REsearch, Université de Nantes, UFR des Sciences Pharmaceutiques, 1 rue Gaston Veil, BP 53508, 44035, Nantes Cedex 1, France. · Institut de Cancérologie de l'Ouest, Site René Gauducheau, Boulevard Jacques Monod, 44805, Saint Herblain Cedex, France. · EA 4275-SPHERE methodS for Patients-centered outcomes and HEalth REsearch, Université de Nantes, UFR des Sciences Pharmaceutiques, 1 rue Gaston Veil, BP 53508, 44035, Nantes Cedex 1, France. · Institut de Cancérologie de l'Ouest, Site René Gauducheau, Boulevard Jacques Monod, 44805, Saint Herblain Cedex, France. · Unité de Cancéro-dermatologie, Centre Hospitalier Universitaire de Nantes, 1 place Alexis-Ricordeau, 44093, Nantes Cedex 1, France. · Pubmed 26886927
2015
  • Department of Medical Oncology, Institut du Cancer de Montpellier, 208 avenue des Apothicaires, 34298 Montpellier Cedex 5, France. · Department of Pathology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, 2 place Saint-Jacques, 25000 Besançon, France. · Department of Medical Oncology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Department of Medical Oncology, ICO Centre René Gauducheau, boulevard Jacques Monod, 44805 Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94800 Villejuif, France. · Department of Medical Oncology, Institut Claudius Régaud, 20/24 Rue du Pont Saint Pierre, 31300 Toulouse, France. · R&D UNICANCER, 101 rue de Tolbiac, 75654 Paris, France. · Department of Pathology, Institut Claudius Régaud, 20/24 rue du Pont Saint Pierre, 31300 Toulouse, France. · Pubmed 26260807
  • Department of Clinical Research, Institut Curie Paris & Saint Cloud, Paris · Centre René Gauducheau, Centre Régional de Lutte Contre le Cancer (CRLC) Nantes, Atlantique, France. · Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, USA. · Institut du Cancer de Montpellier (ICM), Montpellier, France. · The University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · Genentech, Inc., South San Francisco, USA. · Roche Product Development, Shanghai, China. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 26202594
  • Institut Curie, Paris, France. Université Paris Descartes, Paris, France. · Centre Paul Strauss, Strasbourg, France. · Centre François Baclesse, Caen, France. · Centre Antoine Lacassagne, Nice, France. · Institut de Cancérologie de l'Ouest-René Gauducheau, Saint Herblain, France. · APHP Tenon, Alliance pour la Recherche en Cancérologie, Paris, France. Institut Universitaire de Cancérologie-Paris VI, Sorbonne Université, Paris, France. · Institut Curie Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius Regaud, Toulouse, France. · Centre Léon-Bérard, Lyon, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Institut Oscar Lambret, Lille, France. · Roche, Boulogne-Billancourt, France. · Institut Curie, Paris, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Pubmed 25538259
  • Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biopatholgy department, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Départemental de Vendée - site de Montaigu, Polyvalent medicine service, Centre Hospitalier, 54, rue Saint Jacques, BP 259, Montaigu, 85602, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biostatistics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Mathematics laboratory, UMR CNRS 6623 et Université de Franche Comté, 16 route de Gray, Besançon Cedex, 25030, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Medical oncology service, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Pubmed 26597277
  • ‡René Gauducheau ICO Cancer Center, Inserm U892, CNRS 6299, Bd J. Monod, 44805 Saint Herblain Cedex, France; §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · ‡René Gauducheau ICO Cancer Center, Inserm U892, CNRS 6299, Bd J. Monod, 44805 Saint Herblain Cedex, France; · ¶Angers University, 4 Boulevard de Lavoisier, Angers, 49000, France; · ‖INSERM U892, CNRS 6299, IRT-UN, 8 quai Moncousu, 44007 Nantes Cedex, France. · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; ¶Angers University, 4 Boulevard de Lavoisier, Angers, 49000, France; · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · Pubmed 26209610
  • CRCNA, UMR INSERM U892, CNRS 6299, Université de Nantes, Team 8 « Cell Survival and Tumor Escape in Breast Cancers », Institut de Recherche en Santé de l'Université de Nantes, Nantes, France. · Service d'Anatomie Pathologique, HGRL, CHU, Nantes University, Nantes, France. · Institut de Cancérologie de Nantes, Centre de lutte contre le Cancer René Gauducheau, Boulevard Jacques Monod, Nantes, France. · Pubmed 25974963
  • Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Département de Biopathologie, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Anatomie Pathologique B, Hôpital G&R Laënnec, Bd J. Monod, 44805, Saint Herblain, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Biostatistique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Sorbonne Universités, UPMC University, Département de Biostatistique, 4 place Jussieu, 75005, Paris, France. · AP-HP, University Hospitals Pitié-Salpêtrière Charles-Foix, Département de Biostatistique, Santé Publique et Informatique Médicale, 47-83 Bd de l'Hôpital, 75013, Paris, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Pubmed 25887482
2014
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Tumor Bank, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Pathology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · Département de Biologie et de Pathologie, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31052, France. · Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest-René Gauducheau, Boulevard Jacques Monod, Saint-Herblain, Nantes, 44805, France. · R&D UNICANCER, UNICANCER, Rue de Tolbiac 101, Paris, Cedex 13 75654, France. · Département d'Oncologie Médicale, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31300, France. · Department of Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, Brussels, 1200, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Pubmed 25416589
  • Centre René Gauducheau, Service Oncologie Médicale , Nantes Saint-Herblain , France. · Pubmed 25164472
2013
  • Institut de Cancérologie de l'Ouest - Centre Rene Gauducheau , Saint Herblain , France. · Pubmed 23962028
  • Institut de Cancérologie de l'Ouest/René Gauducheau, Centre de Recherche en Cancérologie, UMR-INSERM 892, St Herblain, France. · Pubmed 23528159
  • Institut de Cancérologie de l'Ouest-René Gauducheau, Centre de Recherche en Cancérologie, Boulevard Jacques Monod, 44805 Saint Herblain-Nantes cedex, France. · Pubmed 23735704
2012
  • Centre René-Gauducheau, département d'oncologie médicale, boulevard Jacques-Monod, 44805 Saint-Herblain, Nantes Cedex, France. · Pubmed 22614782
  • Centre René Gauducheau, Nantes-Saint-Herblain, France. · Pubmed 22045498
  • Department of Medical Oncology, Centre René Gauducheau, Nantes Saint-Herblain, France. · Pubmed 21700731
2011
  • Institut du cancer Nantes-Atlantiques, centre René-Gauducheau, Saint-Herblain, France. · Pubmed 21591301
  • Department of Medical Oncology, Centre René Gauducheau, boulevard Jacques Monod, Nantes Saint-Herblain, France. · Pubmed 20684884
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
2015
  • Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Pubmed 25713436
2013
  • Authors' Affiliations: Inserm U1085-IRSET, Equipe Labellisée Ligue Contre Le Cancer; Université de Rennes-1; Centre Eugène Marquis, rue bataille Flandres Dunkerque, Rennes; ImmuSmol, 15 Rue Amiral Prouhet, Pessac; Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, CNRS, UMR 7258, Marseille; ICO-René Gauducheau, Bd J. Monod, Saint-Herblain; Université de Bordeaux; Inserm U1045, Université Bordeaux Segalen; and Inserm U916, Institut Bergonié, Bordeaux, France. · Pubmed 24072745
  • Unité Mixte de Génomique du Cancer, Hôpital Laënnec/Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805 Nantes - Saint Herblain Cedex, France. · Pubmed 23325629
2012
  • Institut du Cancer de l'Ouest Centre René Gauducheau, Bd Jacques Monod, 44805 Saint-Herblain, France. · Pubmed 22316367
  • Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Nantes, France. · Pubmed 22659076
  • Département de Biologie Oncologique, Institut de Cancérologie de l'Ouest - René Gauducheau, Bd J Monod, Nantes - Saint Herblain Cedex, France. · Pubmed 21898387
2011
  • Institut du Cancer de l'Ouest Centre René Gauducheau, Bd Jacques Monod, 44805 Saint-Herblain, France. · Pubmed 22087618
  • Nuclear Medicine Department, Comprehensive Cancer Center René Gauducheau, IRCNA, Saint Herblain, France. · Pubmed 21308372
  • Institut National de la Santé et de la Recherche Médicale, Unité 892, CLCC René Gauducheau, Saint Herblain, France. · Pubmed 21747904
2010
  • Service d'oncologie médicale, centre de lutte contre le cancer René-Gauducheau, institut de cancérologie de Nantes-Atlantique, boulevard Jacques-Monod, 44805 Nantes-Saint-Herblain, France. · Pubmed 21115288
2009
  • Oncologie Médicale, Institut Regional du Cancer Nantes Atlantique CRLCC René Gauducheau, Bd Jacques Monod 44805 Nantes Cedex/Saint-Herblain, France. · Pubmed 19863462
Probable:    Miscellaneous institutions in Nantes      
2017
  • a Medical oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St Herblain , France. · b Medical oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 28395540
  • Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France. · Institut Curie - Hôpital René Huguenin, Saint-Cloud, France. · Centre Georges-Francois Leclerc, Dijon, France. · Institut de Cancérologie de L'Ouest, Nantes, France. · Institut Paoli-Calmettes, Department of Clinical Research and Innovations, Marseille, France. · Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Biopathology, CRCM, Marseille, France. · Institut Paoli-Calmettes, Department of Clinical Research and Innovations, Marseille, France; Aix Marseille University, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de La Santé & Traitement de L'Information Médicale, Marseille, France. · Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France. Electronic address: · Pubmed 28950146
  • a Department of Medical Oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St. Herblain , France. · b Department of Medical Oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Nantes and Angers , Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 29169282
  • Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. · Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Institut du Cancer de Montpellier, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Institut Curie, Paris, France. · Centre François Baclesse, Caen, France. · Centre Eugene Marquis, Rennes, France. · Institut Bergonié, Bordeaux, France. · Centre Léon Bérard, Lyon, France. · Institut Jean Godinot, Reims, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Jean Perrin, Clermont-Ferrand, France. · Laboratoire de biochimie, CHU de Nantes, Nantes, France. · Faculté de médecine, Université de Nantes, Nantes, France; Laboratoire de biochimie, CHU de Nantes, Nantes, France; INSERM UMR 913, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. Electronic address: · Pubmed 28463758
2016
  • Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. Electronic address: · Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laënnec, 69008 Lyon cedex 08, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Université de Bordeaux, institut Bergonie, 229, cours de l'Argonne, 33000 Bordeaux, France. · Hôpital Tenon, université Paris-Sorbonne, Inserm U938, 4, rue de la Chine, 75020 Paris, France. · Institut universitaire du cancer-Toulouse oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Centre Armoricain d'oncologie, Cario, 21, rue du Vieux-Séminaire, 22000 Saint-Brieuc, France. · Université de Montpellier, institut du cancer, IRCM U1194, 34298 Montpellier, France. · Institut de cancérologie de la Loire, 108 B, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France. · R&D Unicancer, 101, rue de Tolbiac, 75013 Paris, France. · Université Aix-Marseille, institut Paoli-Calmettes, Inserm U1068, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. · Université de Bourgogne, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Centre Jean-Bernard, 9, rue Beauverger, 72000 Le Mans, France. · Université de Strasbourg, centre Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67000 Strasbourg, France. · Université d'Auvergne, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Institut d'oncologie de l'Ouest, Inserm U892, IRT-UN, 8, quai Moncousu, 44007 Nantes cedex, France. · Centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France. · Centre Catherine-de-Sienne, 2, rue Éric-Tabarly, 44202 Nantes, France. · CHU de Limoges, service d'oncologie médicale, 22, avenue Martin-Luther-King, 87000 Limoges, France. · Institut Sainte-Catherine, 250, chemin de Baignes-Pieds, 84918 Avignon cedex 9, France. · Ligue nationale contre le cancer, comité du Lot, 28, boulevard Gambetta, 46000 Cahors, France. · Europadonna France, 14, rue Corvisart, 75013 Paris, France. · Université de Lyon, 69000 Lyon, France; Université Lyon 1, 69100 Villeurbanne, France; Centre de recherche en cancérologie de Lyon, Inserm U1052, CNRS UMR5286, 69000 Lyon, France; Centre Léon-Bérard, 69008 Lyon, France. · Registre de Côte d'Or, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Institut Gustave-Roussy, département d'imagerie médicale, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Pubmed 27473920
  • Janssen Research & Development, Spring House, Pennsylvania. · US Oncology, Dallas, Texas. · The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Institut de Cancérologie de l'Ouest, Nantes, France. · Dnepropetrovsk Medical Academy, Municipal Clinical Hospital #4, Dnepropetrovsk, Ukraine. · Leningrad Regional Oncology Dispensary, Saint Petersburg, Russia. · Hôpital René Huguenin, Saint-Cloud, France. · N.N. Blokhin Cancer Research Center, Moscow, Russia. · Research Institute of Oncology, Saint Petersburg, Russia. · CHC, Liège, Belgium. · University Hospitals Leuven, Leuven, Belgium. · Janssen Research & Development, Raritan, New Jersey. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, San Diego, California. · Janssen Research & Development, Spring House, Pennsylvania. · Janssen Research & Development, High Wycombe, United Kingdom. · Janssen Research & Development, Beerse, Belgium. · The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom. · Pubmed 27267854
  • Levine Cancer Institute, Charlotte, NC, USA. · Mission Health Asheville, Asheville, NC, USA. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141, Milan, Italy. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Sylvester Comprehensive Cancer Center at Deerfield Beach, Miller School of Medicine, University of Miami, Miami, FL, USA. · The Northern Hospital, Cooper St, Epping, Australia. · Department of Medical Oncology, Léon-Bérard Centre, Lyon, France. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, WA, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinique du sein, Centre du Cancer, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Oncology, KU Leuven and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Roswell Park Cancer Institute, Buffalo, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · Vianova-Biosciences, Lasne, Belgium. · Pubmed 26993131
  • Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologica di Milano, Via Ripamonti, 435, 20141, Milan, Italy. · Institut régional du Cancer de Montpellier, Montpellier, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Clinique Saint-Pierre, Ottignies, Belgium. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Centre d'Oncologie de Gentilly, Nancy, France. · Medical Oncology Unit, 'Tor Vergata' University Hospital, Rome, Italy. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · GSK Vaccines, Rixensart, Belgium. · Pubmed 26975189
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. · Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Bioinformatics Core Facility, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · R&D, UNICANCER, Paris, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. · Pubmed 27535334
  • Centre Leon Berard, Medical Oncology, Lyon 69008, France. Electronic address: · Institut de Cancérologie de l'Ouest, Saint-Herblain, Nantes, France. · Centre Léon Bérard, Lyon, France. · Pubmed 27155742
  • Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Present address: Institut Curie, Centre de Recherche, UMR 144, 26 Rue d'Ulm, 75248, Paris, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Institut de Cancérologie de Nantes, Centre de Lutte Contre le Cancer René Gauducheau, Boulevard Jacques Monod, 44 805, Saint-Herblain-Nantes Cedex, France. · Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Pubmed 27039296
2015
  • Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biopatholgy department, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Départemental de Vendée - site de Montaigu, Polyvalent medicine service, Centre Hospitalier, 54, rue Saint Jacques, BP 259, Montaigu, 85602, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biostatistics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Mathematics laboratory, UMR CNRS 6623 et Université de Franche Comté, 16 route de Gray, Besançon Cedex, 25030, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Medical oncology service, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Pubmed 26597277
  • Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Institut de Cancérologie de l'Ouest, Boulevard Jacques Monod Saint Herblain-Nantes cedex, Centre de Recherche du Cancer Nantes-Angers, UMR-INSERM U892/CNRS 6299, Nantes, F-44805, France. · Hopital G&R Laënnec, Boulevard Jacques Monod, Saint Herblain-Nantes cedex, Nantes, F-44093, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Pubmed 26449867
  • Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Département de Biopathologie, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Anatomie Pathologique B, Hôpital G&R Laënnec, Bd J. Monod, 44805, Saint Herblain, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Biostatistique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Sorbonne Universités, UPMC University, Département de Biostatistique, 4 place Jussieu, 75005, Paris, France. · AP-HP, University Hospitals Pitié-Salpêtrière Charles-Foix, Département de Biostatistique, Santé Publique et Informatique Médicale, 47-83 Bd de l'Hôpital, 75013, Paris, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Pubmed 25887482
2014
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, International Hereditary Cancer Center, Sczeczin, Poland. · Department of Oncology, Baylor-Charles A. Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, USA. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille. · Department of Medical Oncology, Institut de Cancérologie de l'OUEST, Nantes, France. · Clinical R&D, PharmaMar, Colmenar Viejo, Madrid, Spain. · Pubmed 24692579
  • Department of Therapeutic, EA 1156-12, Division of Geriatric Medicine, Nantes University Hospital, Nantes, France. · Ouest Cancer Institut, UMR-INSERM U892, Nantes, France. · Department of Departmental Geriatrics, Marseille, France. · Department of Neuroscience, UPRES EA 4638, UNAM, Division of Geriatric Medicine, Angers University Hospital, Angers, France. · Ouest Cancer Registry, Nantes, France. · Pubmed 24848085
2012
  • Unité Mixte de Génomique du Cancer, Hôpital Laënnec, Bd J. Monod, 44805, Nantes-Saint Herblain Cedex, France. · Pubmed 21452023
2010
  • Registre des cancers de Loire-Atlantique et de Vendée, 50 route de Saint-Sébastien, Nantes Cedex 1, France. · Pubmed 20409772
2009
  • Service d'Anatomie Pathologique B, Hôpital G&R Laënnec, Bd J Monod, Nantes, Saint Herblain Cedex, France. · Pubmed 19513072
  • Unité Mixte de Génomique du Cancer, Hôpital Laënnec, 44805 Nantes, Saint Herblain Cedex, France. · Pubmed 19020972
Probable:    Miscellaneous cities in France      
2017
  • Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St., Dublin, 7, Ireland. · Division of Early Drug Development, Istituto Europeo di Oncologia, Milan, Italy. · Clinical Investigational Unit, Institut Curie, Paris, France. · Breast UnitKliniken Essen-Mitte, Essen, Germany. · Department of Obstetrics & Gynecology, St.-Johannes-Hospital, Dortmund, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-EMN, Erlangen, Germany. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Centre Leon Berard, Lyon, France. · Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Department of Clinical Oncology, Nottingham University Hospital NHS Trust (City campus), Nottingham, UK. · Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy. · Division of Hematology/Oncology, University of Tennessee Health Science Center, The West Clinic, Medical Oncology, Memphis, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · MGH Cancer Center, Massachusetts General Hospital, Boston, USA. · Pubmed 28176175
2016
  • a Centre René Gauducheau, Institut de Cancérologie de l'Ouest , Boulevard Jacques Monod, Saint-Herblain , France. · b Centre Eugène Marquis , Boulevard de la Bataille Flandres-Dunkerque, Rennes , France. · c Centre Paul Papin, Institut de Cancérologie de l'Ouest , 15 rue André Bocquel, Angers , France. · d UMR INSERM U892 , France. · Pubmed 27484180
  • Institut de cancérologie de l'Ouest, département d'oncologie médicale, 44800 Saint-Herblain, France. · Centre Léon-Bérard, département d'oncologie médicale, 69008 Lyon, France. · Centre Léon-Bérard, département d'oncologie médicale, 69008 Lyon, France. Electronic address: · Pubmed 26992855
2015
  • Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Electronic address: · Institut de Cancerologie de L Ouest, Saint Herblain, France. · Klinika Onkologii I Radioterapii, Uniwersyteckie, Gdansk, Poland. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Crlcc G. Francois Leclerc, Dijon, France. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Fn Motol, Praha, Czech Republic. · Clinique Armoricaine de Radiologie, Saint Brieuc, France. · Hospital Clinic, Barcelona, Spain. · Bristol-Myers Squibb, Wallingford, CT. · Bristol-Myers Squibb, Rome, Italy. · Institut Claudius Regaud, Toulouse, France. · Pubmed 25218708
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 114 total) written by Mario Campone about Breast Neoplasms:

  • Olaparib for the treatment of breast cancer. 2017
  • MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer. 2017
  • PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. 2017
  • Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. 2017
  • Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106). 2017
  • Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR 2017
  • Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study. 2017
  • A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4). 2017
  • Efficacy of buparlisib in treating breast cancer. 2017
  • Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Mario Campone using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
ICO Rene Gauducheau
Miscellaneous institutions in Nantes
Miscellaneous cities in France
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
ICO Rene Gauducheau
2017
  • a Medical oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St Herblain , France. · b Medical oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 28395540
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Centre Eugène Marquis, Rue de la Bataille Flandres-Dunkerque - CS 44229, 35042 Rennes Cedex, France. Electronic address: · Centre Georges-François Leclerc, 1 rue Professeur Marion BP 77990, 21079 Dijon, France. Electronic address: · Institut régional du cancer de Montpellier, Parc Euromédecine, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France. Electronic address: · Centre François Baclesse, 3 av du Général Harris, 14000 Caen, France. Electronic address: · Centre Catherine de Sienne, 2 rue Eric Tabarly, 44202 Nantes, France. Electronic address: · Centre Hospitalier, Avenue de l'Hopital, 12000 Rodez, France. Electronic address: · Centre Paul Papin, 15 rue André Boquel, 49000 Angers, France. Electronic address: · Centre Alexis Vautrin, 6 avenue de Bourgogne, 54419 Vandoeuvre-Lès-Nancy, France. Electronic address: · Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. Electronic address: · Institut Curie, Site de Saint-Cloud, 35 rue Dailly, 92210 Saint-Cloud, France. Electronic address: · Institut Sainte-Catherine, 250 Chemin de Baigne Pieds, 84918 Avignon, France. Electronic address: · Centre hospitalier Émile Müller, 20 rue du Docteur Laennec, 68051 Mulhouse, France. Electronic address: · Institut Bergonié, 229 Cours de l'Argonne, 33000 Bordeaux, France. Electronic address: · Institut de cancérologie de l'ouest, Centre René Gauducheau, Boulevard Professeur Jacques Monod, 44805 Saint-Herblain, France. Electronic address: · Centre Jean Perrin, 58 rue Montalembert, 63000 Clermont-Ferrand, France. Electronic address: · Centre Léon Bérard, 28 prom. Léa et Napoléon Bullukian, 69008 Lyon, France. Electronic address: · Centre hospitalier Bretagne-Sud, 5 avenue de Choiseul, 56322 Lorient, France. Electronic address: · Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-Oncopole, 1 avenue Irèle joliot-Curie, 31059 Toulouse Cedex 9, France. Electronic address: · Pubmed 28501763
  • Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy. · Institut de Cancerologie de l'Ouest, René Gauducheau, Saint-Herblain, France. · Hospital Gasthuisberg, Leuven, Belgium. · Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA. · Pontificia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Duke University Medical Center, Durham, NC, USA. · Moffitt Cancer Center, Tampa, FL, USA. · University of Szeged, Szeged, Hungary. · Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, Bordeaux, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Institut Gustave Roussy, Villejuif, France. · Pubmed 28183331
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Curtin University and Breast Cancer Research Centre, Perth, Australia. · Department of Oncological Research, Sint-Augustinus Hospital, Antwerp, Belgium. · Baylor-Charles A. Sammons Cancer Center, Dallas, USA Texas Oncology, US Oncology, Dallas, USA. · Centro de Oncologia Clínica, Hospital Pérola Byington and FMUSP, Paulo São, Brazil. · City Clinical Oncological Dispensary, Saint Petersburg, Russian Federation. · Hematology and Medical Oncology, Ironwood Cancer and Research Centers, Chandler, USA. · Department of Breast Tumors, Petrov Research Institute of Oncology, Saint Petersburg, Russian Federation. · Medical Oncology Service, Hospital Universitario de Canarias, Tenerife, Spain. · Institut de Cancérologie de l'Ouest, Nantes René Gauducheau Centrede Recherche en Cancérologie, France. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain. · University of Kansas Medical Center, University of Kansas, Kansas City. · Highlands Oncology Group, Fayetteville, USA. · Centro Oncológico de Galicia, La Coruña, Spain. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover. · Novartis Institutes for BioMedical Research, Cambridge, USA. · Novartis Oncology, Paris, France. · Breast Cancer Group, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 27803006
  • a Department of Medical Oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St. Herblain , France. · b Department of Medical Oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Nantes and Angers , Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 29169282
  • Loire-Atlantique/Vendée Cancer Registry, Plateau des écoles, 50 route de St Sébastien, 44093, Nantes Cedex 1, France. · Loire-Atlantique/Vendée Cancer Registry, Plateau des écoles, 50 route de St Sébastien, 44093, Nantes Cedex 1, France. · Institut de Cancérologie de l'Ouest, Site René Gauducheau, Boulevard Jacques Monod, 44805, St Herblain Cedex, France. · CAP Santé Plus 44, 50 route de St Sébastien, CS 96531, 44265, Nantes, France. · Pubmed 27995351
2016
  • a Centre René Gauducheau, Institut de Cancérologie de l'Ouest , Boulevard Jacques Monod, Saint-Herblain , France. · b Centre Eugène Marquis , Boulevard de la Bataille Flandres-Dunkerque, Rennes , France. · c Centre Paul Papin, Institut de Cancérologie de l'Ouest , 15 rue André Bocquel, Angers , France. · d UMR INSERM U892 , France. · Pubmed 27484180
  • Previous address: Churchill Hospital, Oxford University Hospitals NHS Trust and University of Oxford, Oxford, United Kingdom. · School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom. · Department of Oncology, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, United Kingdom. · Department of Oncology, Highlands Oncology Group, Fayetteville, Arkansas, USA. · Department of Oncology, Hospital Clinico Universitario, Santiago de Compostela, Spain. · Department of Medical Oncology, Nuovo Ospedale di Prato, Prato, Italy. · Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Department of Medical Oncology, University of Torino, FPO-IRCCS, Candiolo, Italy. · Department of Medical Oncology, University Hospital, IBIMA, Malaga, Spain. · Department of Medical Oncology, Institut de Cancérologie de l'ouest René Gauducheau, Nantes, France. · Early Clinical Biostatistics, Oncology, Novartis Pharma AG, Basel, Switzerland. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · Oncology Global Development, Novartis Pharma AG, Basel, Switzerland. · Department of Hematology-Oncology, National University Cancer Institute Singapore, Singapore. · Pubmed 27129177
  • Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain · Medical Oncology, Georges Francois Leclerc Centre, Dijon, France. · Department of Oncology, Ninewells Hospital, Dundee, UK. · Medical Oncology, Hospital del Mar, Barcelona Cancer Research Program, IMIM, Barcelona CEXS, Ponpeu Fabra University, Barcelona, Spain. · Hematology -Medical Oncology Department, Levine Cancer Institute, Charlotte, USA. · Medical Oncology, Institute of Cancer Research (ICO) in Western France, Nantes, France. · Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, USA. · Pharma Development Oncology. · Department of Biostatistics. · Oncology Biomarker Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, USA. · Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain. · Pubmed 27052654
  • Institut Paoli-Calmettes, Medical Oncology Department, Marseille, France. · CRO2, Neuro-Oncology Department, UMRS_911, Marseille, France. · APHM, Marseille, France. · Aix-Marseille University, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, Inserm, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, CNRS, Marseille, France. · Institut Curie & Université Paris Descartes, Medical Oncology Department, Paris, France. · Centre Paul Strauss, Medical Oncology Department, Strasbourg, France. · Centre François Baclesse, Medical Oncology Department, Caen, France. · Centre Antoine Lacassagne, Medical Oncology Department, Nice, France. · Centre René Gauducheau, Medical Oncology Department, Saint-Herblin, France. · APHP-Tenon, APREC, Paris, France. · IUC-UPMC, Sorbonne University, Paris, France. · Hopital Rene Huguenin-Institut Curie, Medical Oncology Department, Saint-Cloud, France. · Institut Claudius Regaud, Medical Oncology Department, Toulouse, France. · Institut Leon Berard, Medical Oncology Department, Lyon, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium. · Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Department of Oncology, KU Leuven, Leuven, Belgium. · The University of Texas MD Anderson Cancer Center, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX, USA. · Pubmed 26921265
  • Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Present address: Institut Curie, Centre de Recherche, UMR 144, 26 Rue d'Ulm, 75248, Paris, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Institut de Cancérologie de Nantes, Centre de Lutte Contre le Cancer René Gauducheau, Boulevard Jacques Monod, 44 805, Saint-Herblain-Nantes Cedex, France. · Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Pubmed 27039296
  • EA 4275-SPHERE methodS for Patients-centered outcomes and HEalth REsearch, Université de Nantes, UFR des Sciences Pharmaceutiques, 1 rue Gaston Veil, BP 53508, 44035, Nantes Cedex 1, France. · Institut de Cancérologie de l'Ouest, Site René Gauducheau, Boulevard Jacques Monod, 44805, Saint Herblain Cedex, France. · EA 4275-SPHERE methodS for Patients-centered outcomes and HEalth REsearch, Université de Nantes, UFR des Sciences Pharmaceutiques, 1 rue Gaston Veil, BP 53508, 44035, Nantes Cedex 1, France. · Institut de Cancérologie de l'Ouest, Site René Gauducheau, Boulevard Jacques Monod, 44805, Saint Herblain Cedex, France. · Unité de Cancéro-dermatologie, Centre Hospitalier Universitaire de Nantes, 1 place Alexis-Ricordeau, 44093, Nantes Cedex 1, France. · Pubmed 26886927
2015
  • Department of Medical Oncology, Institut du Cancer de Montpellier, 208 avenue des Apothicaires, 34298 Montpellier Cedex 5, France. · Department of Pathology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, 2 place Saint-Jacques, 25000 Besançon, France. · Department of Medical Oncology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Department of Medical Oncology, ICO Centre René Gauducheau, boulevard Jacques Monod, 44805 Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94800 Villejuif, France. · Department of Medical Oncology, Institut Claudius Régaud, 20/24 Rue du Pont Saint Pierre, 31300 Toulouse, France. · R&D UNICANCER, 101 rue de Tolbiac, 75654 Paris, France. · Department of Pathology, Institut Claudius Régaud, 20/24 rue du Pont Saint Pierre, 31300 Toulouse, France. · Pubmed 26260807
  • Department of Clinical Research, Institut Curie Paris & Saint Cloud, Paris · Centre René Gauducheau, Centre Régional de Lutte Contre le Cancer (CRLC) Nantes, Atlantique, France. · Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, USA. · Institut du Cancer de Montpellier (ICM), Montpellier, France. · The University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · Genentech, Inc., South San Francisco, USA. · Roche Product Development, Shanghai, China. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 26202594
  • Institut Curie, Paris, France. Université Paris Descartes, Paris, France. · Centre Paul Strauss, Strasbourg, France. · Centre François Baclesse, Caen, France. · Centre Antoine Lacassagne, Nice, France. · Institut de Cancérologie de l'Ouest-René Gauducheau, Saint Herblain, France. · APHP Tenon, Alliance pour la Recherche en Cancérologie, Paris, France. Institut Universitaire de Cancérologie-Paris VI, Sorbonne Université, Paris, France. · Institut Curie Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius Regaud, Toulouse, France. · Centre Léon-Bérard, Lyon, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Institut Oscar Lambret, Lille, France. · Roche, Boulogne-Billancourt, France. · Institut Curie, Paris, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Pubmed 25538259
  • Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biopatholgy department, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Départemental de Vendée - site de Montaigu, Polyvalent medicine service, Centre Hospitalier, 54, rue Saint Jacques, BP 259, Montaigu, 85602, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biostatistics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Mathematics laboratory, UMR CNRS 6623 et Université de Franche Comté, 16 route de Gray, Besançon Cedex, 25030, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Medical oncology service, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Pubmed 26597277
  • ‡René Gauducheau ICO Cancer Center, Inserm U892, CNRS 6299, Bd J. Monod, 44805 Saint Herblain Cedex, France; §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · ‡René Gauducheau ICO Cancer Center, Inserm U892, CNRS 6299, Bd J. Monod, 44805 Saint Herblain Cedex, France; · ¶Angers University, 4 Boulevard de Lavoisier, Angers, 49000, France; · ‖INSERM U892, CNRS 6299, IRT-UN, 8 quai Moncousu, 44007 Nantes Cedex, France. · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; ¶Angers University, 4 Boulevard de Lavoisier, Angers, 49000, France; · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · Pubmed 26209610
  • CRCNA, UMR INSERM U892, CNRS 6299, Université de Nantes, Team 8 « Cell Survival and Tumor Escape in Breast Cancers », Institut de Recherche en Santé de l'Université de Nantes, Nantes, France. · Service d'Anatomie Pathologique, HGRL, CHU, Nantes University, Nantes, France. · Institut de Cancérologie de Nantes, Centre de lutte contre le Cancer René Gauducheau, Boulevard Jacques Monod, Nantes, France. · Pubmed 25974963
  • Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Département de Biopathologie, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Anatomie Pathologique B, Hôpital G&R Laënnec, Bd J. Monod, 44805, Saint Herblain, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Biostatistique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Sorbonne Universités, UPMC University, Département de Biostatistique, 4 place Jussieu, 75005, Paris, France. · AP-HP, University Hospitals Pitié-Salpêtrière Charles-Foix, Département de Biostatistique, Santé Publique et Informatique Médicale, 47-83 Bd de l'Hôpital, 75013, Paris, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Pubmed 25887482
2014
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Tumor Bank, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Pathology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · Département de Biologie et de Pathologie, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31052, France. · Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest-René Gauducheau, Boulevard Jacques Monod, Saint-Herblain, Nantes, 44805, France. · R&D UNICANCER, UNICANCER, Rue de Tolbiac 101, Paris, Cedex 13 75654, France. · Département d'Oncologie Médicale, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31300, France. · Department of Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, Brussels, 1200, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Pubmed 25416589
  • Centre René Gauducheau, Service Oncologie Médicale , Nantes Saint-Herblain , France. · Pubmed 25164472
2013
  • Institut de Cancérologie de l'Ouest - Centre Rene Gauducheau , Saint Herblain , France. · Pubmed 23962028
  • Institut de Cancérologie de l'Ouest/René Gauducheau, Centre de Recherche en Cancérologie, UMR-INSERM 892, St Herblain, France. · Pubmed 23528159
  • Institut de Cancérologie de l'Ouest-René Gauducheau, Centre de Recherche en Cancérologie, Boulevard Jacques Monod, 44805 Saint Herblain-Nantes cedex, France. · Pubmed 23735704
2012
  • Centre René-Gauducheau, département d'oncologie médicale, boulevard Jacques-Monod, 44805 Saint-Herblain, Nantes Cedex, France. · Pubmed 22614782
  • Centre René Gauducheau, Nantes-Saint-Herblain, France. · Pubmed 22045498
  • Department of Medical Oncology, Centre René Gauducheau, Nantes Saint-Herblain, France. · Pubmed 21700731
2011
  • Institut du cancer Nantes-Atlantiques, centre René-Gauducheau, Saint-Herblain, France. · Pubmed 21591301
  • Department of Medical Oncology, Centre René Gauducheau, boulevard Jacques Monod, Nantes Saint-Herblain, France. · Pubmed 20684884
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
2015
  • Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Pubmed 25713436
2013
  • Authors' Affiliations: Inserm U1085-IRSET, Equipe Labellisée Ligue Contre Le Cancer; Université de Rennes-1; Centre Eugène Marquis, rue bataille Flandres Dunkerque, Rennes; ImmuSmol, 15 Rue Amiral Prouhet, Pessac; Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, CNRS, UMR 7258, Marseille; ICO-René Gauducheau, Bd J. Monod, Saint-Herblain; Université de Bordeaux; Inserm U1045, Université Bordeaux Segalen; and Inserm U916, Institut Bergonié, Bordeaux, France. · Pubmed 24072745
  • Unité Mixte de Génomique du Cancer, Hôpital Laënnec/Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805 Nantes - Saint Herblain Cedex, France. · Pubmed 23325629
2012
  • Institut du Cancer de l'Ouest Centre René Gauducheau, Bd Jacques Monod, 44805 Saint-Herblain, France. · Pubmed 22316367
  • Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Nantes, France. · Pubmed 22659076
  • Département de Biologie Oncologique, Institut de Cancérologie de l'Ouest - René Gauducheau, Bd J Monod, Nantes - Saint Herblain Cedex, France. · Pubmed 21898387
2011
  • Institut du Cancer de l'Ouest Centre René Gauducheau, Bd Jacques Monod, 44805 Saint-Herblain, France. · Pubmed 22087618
  • Nuclear Medicine Department, Comprehensive Cancer Center René Gauducheau, IRCNA, Saint Herblain, France. · Pubmed 21308372
  • Institut National de la Santé et de la Recherche Médicale, Unité 892, CLCC René Gauducheau, Saint Herblain, France. · Pubmed 21747904
2010
  • Service d'oncologie médicale, centre de lutte contre le cancer René-Gauducheau, institut de cancérologie de Nantes-Atlantique, boulevard Jacques-Monod, 44805 Nantes-Saint-Herblain, France. · Pubmed 21115288
2009
  • Oncologie Médicale, Institut Regional du Cancer Nantes Atlantique CRLCC René Gauducheau, Bd Jacques Monod 44805 Nantes Cedex/Saint-Herblain, France. · Pubmed 19863462
Miscellaneous institutions in Nantes
2017
  • a Medical oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St Herblain , France. · b Medical oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 28395540
  • Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France. · Institut Curie - Hôpital René Huguenin, Saint-Cloud, France. · Centre Georges-Francois Leclerc, Dijon, France. · Institut de Cancérologie de L'Ouest, Nantes, France. · Institut Paoli-Calmettes, Department of Clinical Research and Innovations, Marseille, France. · Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Biopathology, CRCM, Marseille, France. · Institut Paoli-Calmettes, Department of Clinical Research and Innovations, Marseille, France; Aix Marseille University, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de La Santé & Traitement de L'Information Médicale, Marseille, France. · Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France. Electronic address: · Pubmed 28950146
  • a Department of Medical Oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St. Herblain , France. · b Department of Medical Oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Nantes and Angers , Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 29169282
  • Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. · Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Institut du Cancer de Montpellier, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Institut Curie, Paris, France. · Centre François Baclesse, Caen, France. · Centre Eugene Marquis, Rennes, France. · Institut Bergonié, Bordeaux, France. · Centre Léon Bérard, Lyon, France. · Institut Jean Godinot, Reims, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Jean Perrin, Clermont-Ferrand, France. · Laboratoire de biochimie, CHU de Nantes, Nantes, France. · Faculté de médecine, Université de Nantes, Nantes, France; Laboratoire de biochimie, CHU de Nantes, Nantes, France; INSERM UMR 913, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. Electronic address: · Pubmed 28463758
2016
  • Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. Electronic address: · Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laënnec, 69008 Lyon cedex 08, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Université de Bordeaux, institut Bergonie, 229, cours de l'Argonne, 33000 Bordeaux, France. · Hôpital Tenon, université Paris-Sorbonne, Inserm U938, 4, rue de la Chine, 75020 Paris, France. · Institut universitaire du cancer-Toulouse oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Centre Armoricain d'oncologie, Cario, 21, rue du Vieux-Séminaire, 22000 Saint-Brieuc, France. · Université de Montpellier, institut du cancer, IRCM U1194, 34298 Montpellier, France. · Institut de cancérologie de la Loire, 108 B, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France. · R&D Unicancer, 101, rue de Tolbiac, 75013 Paris, France. · Université Aix-Marseille, institut Paoli-Calmettes, Inserm U1068, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. · Université de Bourgogne, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Centre Jean-Bernard, 9, rue Beauverger, 72000 Le Mans, France. · Université de Strasbourg, centre Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67000 Strasbourg, France. · Université d'Auvergne, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Institut d'oncologie de l'Ouest, Inserm U892, IRT-UN, 8, quai Moncousu, 44007 Nantes cedex, France. · Centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France. · Centre Catherine-de-Sienne, 2, rue Éric-Tabarly, 44202 Nantes, France. · CHU de Limoges, service d'oncologie médicale, 22, avenue Martin-Luther-King, 87000 Limoges, France. · Institut Sainte-Catherine, 250, chemin de Baignes-Pieds, 84918 Avignon cedex 9, France. · Ligue nationale contre le cancer, comité du Lot, 28, boulevard Gambetta, 46000 Cahors, France. · Europadonna France, 14, rue Corvisart, 75013 Paris, France. · Université de Lyon, 69000 Lyon, France; Université Lyon 1, 69100 Villeurbanne, France; Centre de recherche en cancérologie de Lyon, Inserm U1052, CNRS UMR5286, 69000 Lyon, France; Centre Léon-Bérard, 69008 Lyon, France. · Registre de Côte d'Or, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Institut Gustave-Roussy, département d'imagerie médicale, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Pubmed 27473920
  • Janssen Research & Development, Spring House, Pennsylvania. · US Oncology, Dallas, Texas. · The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Institut de Cancérologie de l'Ouest, Nantes, France. · Dnepropetrovsk Medical Academy, Municipal Clinical Hospital #4, Dnepropetrovsk, Ukraine. · Leningrad Regional Oncology Dispensary, Saint Petersburg, Russia. · Hôpital René Huguenin, Saint-Cloud, France. · N.N. Blokhin Cancer Research Center, Moscow, Russia. · Research Institute of Oncology, Saint Petersburg, Russia. · CHC, Liège, Belgium. · University Hospitals Leuven, Leuven, Belgium. · Janssen Research & Development, Raritan, New Jersey. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, San Diego, California. · Janssen Research & Development, Spring House, Pennsylvania. · Janssen Research & Development, High Wycombe, United Kingdom. · Janssen Research & Development, Beerse, Belgium. · The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom. · Pubmed 27267854
  • Levine Cancer Institute, Charlotte, NC, USA. · Mission Health Asheville, Asheville, NC, USA. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141, Milan, Italy. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Sylvester Comprehensive Cancer Center at Deerfield Beach, Miller School of Medicine, University of Miami, Miami, FL, USA. · The Northern Hospital, Cooper St, Epping, Australia. · Department of Medical Oncology, Léon-Bérard Centre, Lyon, France. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, WA, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinique du sein, Centre du Cancer, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Oncology, KU Leuven and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Roswell Park Cancer Institute, Buffalo, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · Vianova-Biosciences, Lasne, Belgium. · Pubmed 26993131
  • Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologica di Milano, Via Ripamonti, 435, 20141, Milan, Italy. · Institut régional du Cancer de Montpellier, Montpellier, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Clinique Saint-Pierre, Ottignies, Belgium. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Centre d'Oncologie de Gentilly, Nancy, France. · Medical Oncology Unit, 'Tor Vergata' University Hospital, Rome, Italy. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · GSK Vaccines, Rixensart, Belgium. · Pubmed 26975189
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. · Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Bioinformatics Core Facility, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · R&D, UNICANCER, Paris, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. · Pubmed 27535334
  • Centre Leon Berard, Medical Oncology, Lyon 69008, France. Electronic address: · Institut de Cancérologie de l'Ouest, Saint-Herblain, Nantes, France. · Centre Léon Bérard, Lyon, France. · Pubmed 27155742
  • Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Present address: Institut Curie, Centre de Recherche, UMR 144, 26 Rue d'Ulm, 75248, Paris, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Institut de Cancérologie de Nantes, Centre de Lutte Contre le Cancer René Gauducheau, Boulevard Jacques Monod, 44 805, Saint-Herblain-Nantes Cedex, France. · Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, 02111, USA. · Pubmed 27039296
2015
  • Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biopatholgy department, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Départemental de Vendée - site de Montaigu, Polyvalent medicine service, Centre Hospitalier, 54, rue Saint Jacques, BP 259, Montaigu, 85602, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Cancer Genomic Unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Biostatistics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Mathematics laboratory, UMR CNRS 6623 et Université de Franche Comté, 16 route de Gray, Besançon Cedex, 25030, France. · Bioinfomics unit, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · INSERM U892, IRT-UN, 8 quai Moncousu, Nantes Cedex, 44007, France. · Medical oncology service, Integrated Centre for Oncology - René Gauducheau, Bd J. Monod, Nantes, Saint Herblain Cedex, 44805, France. · Pubmed 26597277
  • Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Institut de Cancérologie de l'Ouest, Boulevard Jacques Monod Saint Herblain-Nantes cedex, Centre de Recherche du Cancer Nantes-Angers, UMR-INSERM U892/CNRS 6299, Nantes, F-44805, France. · Hopital G&R Laënnec, Boulevard Jacques Monod, Saint Herblain-Nantes cedex, Nantes, F-44093, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Pubmed 26449867
  • Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Département de Biopathologie, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Anatomie Pathologique B, Hôpital G&R Laënnec, Bd J. Monod, 44805, Saint Herblain, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Biostatistique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Sorbonne Universités, UPMC University, Département de Biostatistique, 4 place Jussieu, 75005, Paris, France. · AP-HP, University Hospitals Pitié-Salpêtrière Charles-Foix, Département de Biostatistique, Santé Publique et Informatique Médicale, 47-83 Bd de l'Hôpital, 75013, Paris, France. · Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Laboratoire d'Anatomie Pathologique, Institut de Cancérologie de l'Ouest - site Paul Papin, 2 rue Moll, 49933, Angers Cedex 9, France. · Unité de Bioinfomique, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · INSERM U892, IRT-UN, 8 quai Moncousu, 44007, Nantes Cedex, France. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805, Saint Herblain Cedex, France. · Pubmed 25887482
2014
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, International Hereditary Cancer Center, Sczeczin, Poland. · Department of Oncology, Baylor-Charles A. Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, USA. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille. · Department of Medical Oncology, Institut de Cancérologie de l'OUEST, Nantes, France. · Clinical R&D, PharmaMar, Colmenar Viejo, Madrid, Spain. · Pubmed 24692579
  • Department of Therapeutic, EA 1156-12, Division of Geriatric Medicine, Nantes University Hospital, Nantes, France. · Ouest Cancer Institut, UMR-INSERM U892, Nantes, France. · Department of Departmental Geriatrics, Marseille, France. · Department of Neuroscience, UPRES EA 4638, UNAM, Division of Geriatric Medicine, Angers University Hospital, Angers, France. · Ouest Cancer Registry, Nantes, France. · Pubmed 24848085
2012
  • Unité Mixte de Génomique du Cancer, Hôpital Laënnec, Bd J. Monod, 44805, Nantes-Saint Herblain Cedex, France. · Pubmed 21452023
2010
  • Registre des cancers de Loire-Atlantique et de Vendée, 50 route de Saint-Sébastien, Nantes Cedex 1, France. · Pubmed 20409772
2009
  • Service d'Anatomie Pathologique B, Hôpital G&R Laënnec, Bd J Monod, Nantes, Saint Herblain Cedex, France. · Pubmed 19513072
  • Unité Mixte de Génomique du Cancer, Hôpital Laënnec, 44805 Nantes, Saint Herblain Cedex, France. · Pubmed 19020972
Miscellaneous cities in France
2017
  • Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St., Dublin, 7, Ireland. · Division of Early Drug Development, Istituto Europeo di Oncologia, Milan, Italy. · Clinical Investigational Unit, Institut Curie, Paris, France. · Breast UnitKliniken Essen-Mitte, Essen, Germany. · Department of Obstetrics & Gynecology, St.-Johannes-Hospital, Dortmund, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-EMN, Erlangen, Germany. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Centre Leon Berard, Lyon, France. · Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Department of Clinical Oncology, Nottingham University Hospital NHS Trust (City campus), Nottingham, UK. · Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy. · Division of Hematology/Oncology, University of Tennessee Health Science Center, The West Clinic, Medical Oncology, Memphis, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · MGH Cancer Center, Massachusetts General Hospital, Boston, USA. · Pubmed 28176175
2016
  • a Centre René Gauducheau, Institut de Cancérologie de l'Ouest , Boulevard Jacques Monod, Saint-Herblain , France. · b Centre Eugène Marquis , Boulevard de la Bataille Flandres-Dunkerque, Rennes , France. · c Centre Paul Papin, Institut de Cancérologie de l'Ouest , 15 rue André Bocquel, Angers , France. · d UMR INSERM U892 , France. · Pubmed 27484180
  • Institut de cancérologie de l'Ouest, département d'oncologie médicale, 44800 Saint-Herblain, France. · Centre Léon-Bérard, département d'oncologie médicale, 69008 Lyon, France. · Centre Léon-Bérard, département d'oncologie médicale, 69008 Lyon, France. Electronic address: · Pubmed 26992855
2015
  • Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Electronic address: · Institut de Cancerologie de L Ouest, Saint Herblain, France. · Klinika Onkologii I Radioterapii, Uniwersyteckie, Gdansk, Poland. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Crlcc G. Francois Leclerc, Dijon, France. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Fn Motol, Praha, Czech Republic. · Clinique Armoricaine de Radiologie, Saint Brieuc, France. · Hospital Clinic, Barcelona, Spain. · Bristol-Myers Squibb, Wallingford, CT. · Bristol-Myers Squibb, Rome, Italy. · Institut Claudius Regaud, Toulouse, France. · Pubmed 25218708
Miscellaneous institutions in Angers
2017
  • a Medical oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St Herblain , France. · b Medical oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 28395540
  • a Department of Medical Oncology , Institut de Cancérologie de l'Ouest, René Gauducheau , St. Herblain , France. · b Department of Medical Oncology , Institut de Cancérologie de l'Ouest, Paul Papin , Angers , France. · c Nantes and Angers , Centre de Recherche en Cancérologie Nantes-Angers (CRNA) , France. · Pubmed 29169282
2015
  • Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Institut de Cancérologie de l'Ouest, Boulevard Jacques Monod Saint Herblain-Nantes cedex, Centre de Recherche du Cancer Nantes-Angers, UMR-INSERM U892/CNRS 6299, Nantes, F-44805, France. · Hopital G&R Laënnec, Boulevard Jacques Monod, Saint Herblain-Nantes cedex, Nantes, F-44093, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Oniris, Université Nantes-Angers-Le Mans, Department of Human Health, Biomedical Research and Animal Models, AMaROC Unit and LDHvet laboratory, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Site de la Chantrerie, Route de Gachet, Nantes, F-44307, France. · Pubmed 26449867
Unspecified
2016
  • CNRS, UMR 7292, « Genetics, Immunotherapy, Chemistry and Cancer », Université François Rabelais de Tours, Tours. · CHRU de Tours, Clinique d'Oncologie et de Radiothérapie, Tours. · Department of Medical Oncology/Cancer Research Center UMR-INSERM, U892/CNRS 6299/Bioinformatics Unit, Institut de Cancérologie de l'Ouest, Nantes. · Faculté de Pharmacie, Université de Lorraine, Nancy. · CNRS UMR7039 CRAN, Vandoeuvre les Nancy. · Service de Biopathologie, Institut de Cancérologie de Lorraine, Vandoeuvre les Nancy. · CHRU de Tours, Service d'Immunologie, Tours. · Department of Medical Oncology, Centre Léon Bérard, INSERM U1052, Lyon. · Department of Radiopharmacology, Institut Curie-René Huguenin Hospital, Saint-Cloud. · Department of Medical Oncology, Gustave Roussy, Villejuif. · R&D Unicancer, UNICANCER, Paris. · CHRU de Tours, Laboratoire de Pharmacologie-Toxicologie, Tours, France. · Pubmed 26714164
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center/US Oncology, Dallas, USA · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes. · Departments of Clinical Research and Medical Oncology, Hôpital René Huguenin, Saint-Cloud, France. · Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium. · Breast Oncology Program, The University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Oncology Department, Municipal Clinical Hospital #4, State Medical Academy, Dnepropetrovsk, Ukraine. · Janssen Research & Development, Los Angeles, USA. · Janssen Research & Development, High Wycombe, UK. · Janssen Research & Development, Beerse, Belgium. · Department of Medicine, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Pubmed 26504153
  • Department of Cancer Medicine, Institut Gustave Roussy, Villejuif · Department of Biostatistics, Centre Léon Bérard, Lyon. · Department of Research and Development, R&D Unicancer, Paris. · Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud. · Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes and Angers. · Department of Medical Oncology, Centre François Baclesse, Caen. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · Department of Medical Oncology, Centre Henri Becquerel, Rouen. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice. · Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy. · Department of Medical Oncology, Centre Eugène Marquis, Rennes. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille. · Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims. · Department of Medical Oncology, Centre Oscar Lambret, Lille. · Capionis, Paris, France. · Pubmed 27436849
2015
2011
  • Departments of Medical Oncology, Medical Information, Pathology, CAC GF Leclerc, IFR 100, Dijon. · Pubmed 20693300
ICO Paul Papin
2016
  • a Centre René Gauducheau, Institut de Cancérologie de l'Ouest , Boulevard Jacques Monod, Saint-Herblain , France. · b Centre Eugène Marquis , Boulevard de la Bataille Flandres-Dunkerque, Rennes , France. · c Centre Paul Papin, Institut de Cancérologie de l'Ouest , 15 rue André Bocquel, Angers , France. · d UMR INSERM U892 , France. · Pubmed 27484180
2015
  • ‡René Gauducheau ICO Cancer Center, Inserm U892, CNRS 6299, Bd J. Monod, 44805 Saint Herblain Cedex, France; §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · ‡René Gauducheau ICO Cancer Center, Inserm U892, CNRS 6299, Bd J. Monod, 44805 Saint Herblain Cedex, France; · ¶Angers University, 4 Boulevard de Lavoisier, Angers, 49000, France; · ‖INSERM U892, CNRS 6299, IRT-UN, 8 quai Moncousu, 44007 Nantes Cedex, France. · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; ¶Angers University, 4 Boulevard de Lavoisier, Angers, 49000, France; · §Paul Papin ICO Cancer Center, Inserm U892, CNRS 6299, 2 rue Moll, 49933 Angers Cedex 9, France; · Pubmed 26209610
2014
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
2014
  • Medical Oncology Department, Institut de Cancérologie de l'Ouest Paul Papin, 2 Rue Moll, 49933, Angers Cedex 9, France, · Pubmed 24481998
Universite de Nantes
2015
  • CRCNA, UMR INSERM U892, CNRS 6299, Université de Nantes, Team 8 « Cell Survival and Tumor Escape in Breast Cancers », Institut de Recherche en Santé de l'Université de Nantes, Nantes, France. · Service d'Anatomie Pathologique, HGRL, CHU, Nantes University, Nantes, France. · Institut de Cancérologie de Nantes, Centre de lutte contre le Cancer René Gauducheau, Boulevard Jacques Monod, Nantes, France. · Pubmed 25974963
2011
  • Centre de Recherche en Cancérologie Nantes-Angers - UMR 892 - INSERM/Université de Nantes, Institut de Recherche Thérapeutique de l'Université de Nantes 8 Quai Moncousu BP 7072144007 Nantes Cedex 1 France. · Pubmed 21899728
2016
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Pubmed 25713436
2012
  • Team 8 "Cell survival and tumor escape in breast cancer," UMR 892 INSERM/6299 CNRS/Université de Nantes, Institut de Recherche Thérapeutique de l'Université de Nantes, 8, quai Moncousu, BP 70721, 44007 Nantes Cedex 1, France. · Pubmed 22703841
2009
  • Département de Recherche en Cancérologie, Université de Nantes, INSERM U892, 9 quai Moncousu, 44035 Nantes Cedex, France. · Pubmed 19640729
75 Other Locations Show
Yearly article counts 0112011111816126900
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.